Compare NEOG & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEOG | INSP |
|---|---|---|
| Founded | 1981 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.7B |
| IPO Year | 1995 | 2018 |
| Metric | NEOG | INSP |
|---|---|---|
| Price | $11.64 | $61.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 16 |
| Target Price | $10.67 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 2.2M | 700.3K |
| Earning Date | 04-09-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 99.20 | ★ 179.43 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $870,400,000.00 | $82,050,000.00 |
| Revenue This Year | N/A | $8.02 |
| Revenue Next Year | N/A | $8.11 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $4.90 | $38.91 |
| 52 Week High | $12.85 | $147.03 |
| Indicator | NEOG | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 56.74 | 63.59 |
| Support Level | $8.86 | $56.50 |
| Resistance Level | $12.85 | $66.21 |
| Average True Range (ATR) | 0.39 | 2.10 |
| MACD | -0.06 | 0.04 |
| Stochastic Oscillator | 42.34 | 77.96 |
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.